NCT00013598
- Conditions
- Body Weight, Carotid Intimal Medial Thickness 1, Diabetes Mellitus, +19 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Clinical trial condition
Non-alcoholic Fatty Liver Disease
Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.
1,138 public trials
175 recruiting studies
Non-alcoholic Fatty Liver Disease trial results
Completed
Leptin to Treat Lipodystrophy
NCT00005905
- Conditions
- Diabetes Mellitus, Digestive System Diseases, Dyslipidemias, +14 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
NCT00389376
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Completed
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
NCT00160407
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +14 more
- Locations
-
- Saint Louis University St Louis, Missouri, United States
- Brooke Army Medical Center San Antonio, Texas, United States
NCT00492700
- Conditions
- Body Weight, Diabetes Mellitus, Digestive System Diseases, +16 more
- Locations
-
- Service d'hépatogastroenérologie, Hôpital Pitié Salpêtrière Paris, France
Active, Not Recruiting
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
NCT06947304
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +5 more
- Locations
-
- University of Missouri Columbia, Missouri, United States
Active, Not Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry
NCT07335198
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- GSK Investigational Site Auckland, New Zealand
Active, Not Recruiting
Effect of a GnRH Analog on Hepatic Steatosis
NCT06523530
- Conditions
- Digestive System Diseases, Endometriosis, Fatty Liver, +13 more
- Locations
-
- 424 General Military Hospital Thessaloniki, Greece
- 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki Thessaloniki, Greece
Active, Not Recruiting
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
NCT06005012
- Conditions
- Digestive System Diseases, Fatty Liver, Fibrosis, +8 more
- Locations
-
- University of California, San Diego La Jolla, California, United States
Active, Not Recruiting
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
NCT07024212
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- The Affiliated Hospital of Hangzhou Normal University Hangzhou, Zhejiang, China
- The First Hospital of Jilin University Changchun, China
- Nanjing Gulou Hospital Nanjing, China
- Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong